Herzklappen-Gerätemarktgröße, Wert, Ausblick & Nachfrageeinblicke Bis 2030

Global Heart Valve Devices Market

Marktgröße in Milliarden USD

CAGR : 13.40 %

Prognosezeitraum	2023 –2030
Marktgröße (Basisjahr)	MILLIONEN USD Anfrage
Marktgröße (Prognosejahr)	USD 23,665.51
CAGR	13.40 %
Wichtige Marktteilnehmer	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Anfrage zur Freischaltung

Globaler Markt für Herzklappengeräte, nach Produkttyp (mechanische Herzklappen, biologische Herzklappen und Transkatheterklappen), Behandlung (offene Chirurgie und minimalinvasive Chirurgie (MIS)), Endbenutzer (Krankenhäuser und Kliniken, ambulante chirurgische Zentren , Herzzentren, Forschungszentren und andere), Vertriebskanal (direkte Ausschreibung, Drittanbieter), Branchentrends und Prognose bis 2030.

Marktanalyse und Einblicke zu Herzklappengeräten

Herzklappenimplantate werden zur Behandlung blockierter Herzklappen eingesetzt und das Einsetzen dieser Implantate ist einer der häufigsten Eingriffe. Zu den auf dem Markt erhältlichen strukturellen Herzklappenimplantaten gehören mechanische, biologische und Transkatheterklappen. Der globale Markt für Herzklappenimplantate dürfte im Prognosezeitraum aufgrund der steigenden Zahl von Herzklappenoperationen weltweit stetig wachsen. Das Wachstum des globalen Marktes für Herzklappenimplantate wird voraussichtlich durch Entwicklungen bei strukturellen Herzimplantaten und -verfahren wie Aortenklappen, Linksvorhofverschlussimplantaten und Gewebe- oder biologischen Klappen vorangetrieben. Gewebeklappen haben den Markt für Herzklappenimplantate bereits revolutioniert. Herzklappenoperationen der nächsten Generation bieten Patientenprofile mit geringerer Einlieferungsdauer, kontrolliertere Operationen, bessere Klappenfunktion, reduzierte paravalvuläre Regurgitation, erhöhte Haltbarkeit und niedrigere Kosten. Produktinnovationen wichtiger Marktteilnehmer haben das Marktwachstum angekurbelt, da sie es ihnen ermöglichten, eine größere Patientenpopulation zu behandeln und bessere klinische Ergebnisse zu erzielen.

Data Bridge Market Research analysiert, dass der Markt für Herzklappengeräte bis 2030 voraussichtlich einen Wert von 23.665,51 Millionen USD erreichen wird, was einer durchschnittlichen jährlichen Wachstumsrate von 13,4 % während des Prognosezeitraums entspricht. Der Produkttyp macht aufgrund der weltweit hohen Nachfrage nach Herzklappengeräten das größte Typensegment auf dem Markt aus. Dieser Marktbericht behandelt auch ausführlich Preisanalysen, Patentanalysen und technologische Fortschritte.

Berichtsmetrik	Details
Prognosezeitraum	2023 bis 2030
Basisjahr	2022
Historische Jahre	2021 (Anpassbar auf 2020 – 2015)
Quantitative Einheiten	Umsatz in Mio. USD, Mengen in Einheiten, Preise in USD
Abgedeckte Segmente	Nach Produkttyp (mechanische Herzklappen, biologische Herzklappen und Transkatheterklappen), Behandlung (offene Chirurgie und minimalinvasive Chirurgie (MIS)), Endbenutzer (Krankenhäuser und Kliniken, ambulante chirurgische Zentren, Herzzentren, Forschungszentren und andere), Vertriebskanal (direkte Ausschreibung, Drittanbieter).
Abgedeckte Länder	USA, Kanada, Mexiko, Deutschland, Frankreich, Großbritannien, Italien, Russland, Spanien, Niederlande, Schweiz, Norwegen, Polen, Schweden, Belgien, Türkei, Dänemark, Finnland und der Rest von Europa, China, Japan, Indien, Australien, Neuseeland, Südkorea, Singapur, Malaysia, Thailand, Indonesien, Philippinen, Vietnam, Taiwan und der Rest von Asien-Pazifik, Südafrika, Saudi-Arabien, Bahrain, Vereinigte Arabische Emirate, Kuwait, Oman, Katar, Israel, Ägypten und der Rest von Nahem Osten und Afrika, Brasilien, Argentinien und der Rest von Südamerika.
Abgedeckte Marktteilnehmer	Abbott, Boston Scientific Corporation oder ihre Tochtergesellschaften, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve und andere.

Globale Marktdefinition für Herzklappengeräte

Herzklappen sind notwendig, um den Blutfluss im Körper in die richtige Richtung zu lenken. Herzklappen sind für einen konstanten Blutfluss und die Aufrechterhaltung des Blutdrucks verantwortlich. Wenn sie nicht richtig funktionieren, verursacht eine Unterbrechung des Herzkreislaufs eine Stenose. Herzkrankheiten umfassen im Allgemeinen mehrere Krankheiten, die das Herz erheblich beeinträchtigen. Die Regulierung der Herzklappen hat in den letzten zehn Jahren stark zugenommen, da die Zahl der Patienten mit Herz-Kreislauf-Erkrankungen zugenommen hat. Das Marktwachstum für Herzklappen wird durch Faktoren wie instabile Lebensführung, Zivilisationskrankheiten, zunehmende Raucherbevölkerung, alternde Bevölkerung und zunehmende Qualität der Gesundheitsversorgung sowie eine schnelle Entwicklung der Kostenerstattung im Gesundheitswesen während des Prognosezeitraums beschleunigt. Darüber hinaus könnten die hohen Kosten für Herzklappen und das Infektionsrisiko von Herzimplantaten der Grund sein, der das Wachstum des Herzklappenmarktes während des oben genannten Prognosezeitraums wahrscheinlich verlangsamen wird. Das Wachstum in medizinischen Geschäftsaspekten und die Grundlagenarbeit in Schwellenländern treibt das Wachstum des Medizintourismus an und treibt den Markt für Herzklappengeräte an. Der Bedarf an minimalinvasiven Verfahren zur Behandlung von Herzanomalien ist stark gestiegen. Aktuelle Automatisierungsanwendungen in der Herzklappenchirurgie, wie z. B. der transkatheterale Aortenklappenersatz (TAVR), haben einer wachsenden Vielfalt ähnlicher Operationen Platz gemacht. Gemessen an der zunehmenden Alterung der Bevölkerung dürfte auch die Zunahme der Lebensversicherungspolicen zum Wachstum des Herzklappenmarktes beitragen.

Globale Marktdynamik für Herzklappengeräte

In diesem Abschnitt geht es um das Verständnis der Markttreiber, Vorteile, Chancen, Einschränkungen und Herausforderungen. All dies wird im Folgenden ausführlich erläutert:

Treiber

Innovationen bei Herzklappenimplantaten ermöglichen bessere klinische Ergebnisse

Die Einführung neuer Produkte für minimalinvasive Eingriffe wird wahrscheinlich den globalen Markt für Herzklappengeräte ankurbeln. Gewebeklappen haben den Herzklappenmarkt revolutioniert. Die nächste Generation der Herzklappenchirurgie bietet weniger Einführkurven, eine kontrolliertere Platzierung, eine verbesserte Klappenfunktion, weniger Klappeninsuffizienz, eine längere Haltbarkeit und geringere Kosten. Produktinnovationen haben die Wachstumsaussichten der Akteure auf dem Markt für Herzklappengeräte verbessert, da sie eine größere Anzahl von Patienten mit besseren klinischen Ergebnissen behandeln können. Trotz erheblicher Fortschritte in den letzten Jahren bleibt die strukturelle interventionelle Kardiologie ein aufstrebender Markt mit großem Potenzial.

Darüber hinaus erweitern intelligente Designs, neue Technologien und Biomaterialanwendungen weiterhin die Grenzen der Entwicklung neuer Produkte und stellen sicher, dass diese Geräte auch in den kommenden Jahren an der Spitze der interventionellen Produktinnovation stehen werden. Designinnovationen helfen den Marktteilnehmern, profitable Wachstumschancen bei Herzklappengeräten zu nutzen.

Daher wird erwartet, dass sich das Wachstum des globalen Marktes für Herzklappengeräte aufgrund der zunehmenden Innovationen im Bereich der Herzklappengeräte beschleunigen wird.

Steigende Zahl verschiedener Herzerkrankungen

Herzinfarkte und Schlaganfälle sind in der Regel akute Ereignisse und werden in erster Linie durch eine Blockade verursacht, die den Blutfluss zum Herzen oder Gehirn blockiert. Im ersten Jahr der COVID-19-Pandemie stiegen die Todesfälle durch Herzkrankheiten und Schlaganfälle um 5,8 % bzw. 6,8 %. Die altersbedingten Anstiege betrugen jedoch 1,6 % bzw. 1,7 % für Herzkrankheiten und Schlaganfälle. Die häufigste Ursache ist die Bildung von Fettablagerungen in der Auskleidung der Blutgefäße, die das Herz oder das Gehirn versorgen. Ein Schlaganfall kann durch Blutungen oder Blutgerinnsel in einem Blutgefäß im Gehirn verursacht werden. Dieser Trend deutet darauf hin, dass die Häufigkeit von Herz-Kreislauf-Erkrankungen aufgrund des Bevölkerungswachstums und der Alterung dramatisch zunehmen könnte.

Darüber hinaus sind Diabetes, Bluthochdruck, hoher Cholesterinspiegel und Rauchen wichtige Risikofaktoren für Herzerkrankungen. Etwa die Hälfte der Menschen in den Vereinigten Staaten (47 %) weist mindestens einen dieser drei Risikofaktoren auf. Auch andere Erkrankungen und Lebensstilentscheidungen können das Risiko für Herzerkrankungen erhöhen, darunter ungesunde Ernährung, Bewegungsmangel und übermäßiger Alkoholkonsum.

Darüber hinaus wird erwartet, dass die steigende Zahl an Herzerkrankungen den weltweiten Markt für Herzklappenimplantate ankurbeln wird.

Gelegenheit

Sensibilisierung für Prothesen

Eine Prothese ist ein Gerät, das einen fehlenden Körperteil ersetzen oder die Funktion eines Körperteils verbessern soll. Künstliche Herzklappen werden zunehmend in Fällen von Anomalien der natürlichen Klappen eingesetzt, die einen Eingriff erfordern. Im Allgemeinen können sie in mechanische Herzklappen, biologische Klappen und allogene Transplantate unterteilt werden. Das Ziel künstlicher Klappen besteht darin, hämodynamisch wie eine natürliche Klappe zu wirken und dabei möglichst wenige Nebenwirkungen zu verursachen. Herz-Kreislauf-Prothesen wurden entwickelt, um beschädigtes Herzgewebe zu ersetzen. Diese medizinischen Geräte sollen die Funktion normaler Herz-Kreislauf-Organe nachahmen. Künstliche Herzen ermöglichen Herzchirurgen eine bessere Behandlung von Herzblockaden.

Darüber hinaus liegt die Prävalenz künstlicher Herzklappen zwischen 0,2 pro 1.000 Personen im Alter von 14 bis 24 Jahren und 5,3 pro 1.000 Personen im Alter von 14 bis 24 Jahren.

Daher stellt das zunehmende Bewusstsein für Prothesen eine Chance für das Wachstum des Marktes dar.

Einschränkung/Herausforderung

Hohe Produktionskosten für die Ausrüstung

Die Zahl der Patienten, die in den USA wegen einer Aortenklappenerkrankung behandelt werden, wächst schnell. Der transkatheterale Aortenklappenersatz (TAVR) ersetzt den chirurgischen Aortenklappenersatz (SAVR) und die medikamentöse Behandlung (MT). Die wirtschaftlichen Folgen dieser Trends sind unbekannt. Daher sind die Gesamtkosten von TAVR höher als die von SAVR und viel teurer als die MT allein. Die TAVR-Kosten sind im Laufe der Zeit gesunken, während die Kosten von SAVR und MT gleich geblieben sind.

Darüber hinaus sind die hohen Operationskosten bei TAVI hauptsächlich auf die hohen Produktionskosten zurückzuführen. Aufgrund des kürzeren Krankenhausaufenthalts sind die Kosten bei nicht-chirurgischer TAVI jedoch im Vergleich zu AVR niedriger. Die Kosten für das TAVI-Implantatset allein (Ventil, Ballon, Hülle) betragen 32.500 US-Dollar, während das chirurgische Ventil nur etwa 5.000 US-Dollar kostet. In der Schweiz kostet das TAVI-Implantatset etwa 32.000 Franken (etwa 35.000 US-Dollar), während die Kosten für eine biochirurgische Prothese etwa 3.000 Schweizer Franken (etwa 3.300 US-Dollar) betragen. Je nach Komorbiditäten und Komplikationen beträgt die Erstattung in den USA zwischen 0.000 und 5.000 US-Dollar, in der Schweiz beträgt die TAVI etwa 72.000 Franken (78.000 US-Dollar) und die AVR etwa 3.000 Franken (7.000 US-Dollar), was einen finanziellen Verlust für das Krankenhaus bedeutet.

Daher könnten die steigenden Produktionskosten der Ausrüstung das Marktwachstum behindern.

Jüngste Entwicklungen

Im September 2023 veröffentlichte Abbott Daten aus fünf Präsentationen im Spätstadium, die die Vorteile seiner minimalinvasiven Geräte bei der Behandlung von Menschen mit verschiedenen strukturellen Herzerkrankungen zeigten. Die Daten enthalten Erkenntnisse, die den Wert von MitraClip™ unterstützen. Es handelt sich um die weltweit erste und führende transkatheterale Edge-to-Edge-Reparatur (TEER) zur Behandlung undichter Herzklappen bei Menschen mit Mitralklappeninsuffizienz (MR). Neue Daten zu Abbotts strukturellen Herztherapien wurden auf dem 34. jährlichen wissenschaftlichen Symposium zur transkatheteralen kardiovaskulären Therapie (TCT) der Cardiovascular Research Foundation in Boston vorgestellt. Dies hat dem Unternehmen geholfen, seine Geschäftsposition auf dem Markt auszubauen.
Im September 2020 gab die Boston Scientific Corporation bekannt, dass sie eine kontrollierte Markteinführung des Aortenklappensystems ACURATE neo2™ in Europa eingeleitet hat. Diese Technologie der nächsten Generation zur transkatheteralen Aortenklappenimplantation (TAVI) ist eine neue Plattform mit zahlreichen Funktionen zur Verbesserung der klinischen Leistung der ursprünglichen neuen ACURATE-Plattform. Im Vergleich zur vorherigen Generation verfügt das ACURATE neo2-Klappensystem über eine erweiterte Indikation für Patienten mit Aortenstenose. Dies hat dem Unternehmen geholfen, sein Produktportfolio zu erweitern.

Globaler Markt für Herzklappengeräte

Der Markt für Herzklappengeräte ist nach Produkttyp, Behandlung, Endverbraucher und Vertriebskanal segmentiert. Das Wachstum zwischen den Segmenten hilft Ihnen bei der Analyse von Wachstumsnischen und Strategien zur Marktbearbeitung und zur Bestimmung Ihrer Hauptanwendungsbereiche und der Unterschiede in Ihren Zielmärkten.

NACH PRODUKTTYP

Mechanische Herzklappen
Biologische Herzklappen
Transkatheter-Ventile

Auf der Grundlage des Produkttyps ist der Markt für Herzklappengeräte in mechanische Herzklappen, biologische Herzklappen und Transkatheterklappen segmentiert.

DURCH BEHANDLUNG

OFFENE CHIRURGIE
MINIMALINVASIVER CHIRURGIE

Auf Grundlage der Behandlung ist der Markt für Herzklappengeräte in offene Chirurgie und minimalinvasive Chirurgie segmentiert.

DURCH ENDBENUTZER

KRANKENHAUS & KLINIKEN
AMBULANTE CHIRURGISCHE ZENTREN
HERZZENTREN
FORSCHUNGSZENTREN
ANDERE

Auf der Grundlage des Endbenutzers ist der Markt für Herzklappengeräte in Krankenhäuser und Kliniken, ambulante chirurgische Zentren, Kardiologiezentren, Forschungszentren und andere unterteilt.

NACH VERTRIEBSKANAL

DIREKTE AUSSCHREIBUNG
DRITTANBIETER

Auf der Grundlage der Vertriebskanäle ist der Markt für Herzklappengeräte in Direktausschreibungen und Drittanbieter unterteilt.

Globaler Markt für Herzklappengeräte – Regionale Analyse/Einblicke

Der Markt für Herzklappengeräte wird analysiert und Informationen zur Marktgröße werden hinsichtlich Produkttyp, Behandlung, Endbenutzer und Vertriebskanal bereitgestellt.

Die in diesem Marktbericht abgedeckten Länder sind: USA, Kanada, Mexiko, Deutschland, Frankreich, Großbritannien, Italien, Russland, Spanien, Niederlande, Schweiz, Norwegen, Polen, Schweden, Belgien, Türkei, Dänemark, Finnland und der Rest von Europa, China, Japan, Indien, Australien, Neuseeland, Südkorea, Singapur, Malaysia, Thailand, Indonesien, Philippinen, Vietnam, Taiwan und der Rest des asiatisch-pazifischen Raums, Südafrika, Saudi-Arabien, Bahrain, Vereinigte Arabische Emirate, Kuwait, Oman, Katar, Israel, Ägypten und der Rest des Nahen Ostens und Afrikas, Brasilien, Argentinien und der Rest von Südamerika.

Nordamerika dominiert den Markt aufgrund der steigenden Investitionen in Forschung und Entwicklung. Die USA dominieren die Region Nordamerika aufgrund der starken Präsenz wichtiger Akteure. Deutschland dominiert die Region Europa aufgrund der Massenproduktion von Herzklappengeräten und der steigenden Nachfrage aus Schwellenmärkten und der Expansion der Gesundheitsbranche. China dominiert die Region Asien-Pazifik aufgrund der steigenden Verfügbarkeit von Geräten für die Operation bei Herzklappenerkrankungen.

Der Länderabschnitt des Berichts enthält auch individuelle marktbeeinflussende Faktoren und Änderungen der Regulierung auf dem Inlandsmarkt, die sich auf die aktuellen und zukünftigen Markttrends auswirken. Datenpunkte wie Neuverkäufe, Ersatzverkäufe, demografische Daten des Landes, Regulierungsgesetze und Import-/Exportzölle sind einige der wichtigsten Anhaltspunkte, die zur Prognose des Marktszenarios für einzelne Länder verwendet werden. Bei der Prognoseanalyse der Länderdaten werden auch die Präsenz und Verfügbarkeit globaler Marken und ihre Herausforderungen aufgrund großer oder geringer Konkurrenz durch lokale und inländische Marken sowie die Auswirkungen der Vertriebskanäle berücksichtigt.

Wettbewerbsumfeld und globale Marktanteilsanalyse für Herzklappengeräte

Die Wettbewerbslandschaft auf dem Markt für Herzklappengeräte liefert Details nach Wettbewerbern. Die enthaltenen Details sind Unternehmensübersicht, Unternehmensfinanzen, erzielter Umsatz, Marktpotenzial, Investitionen in Forschung und Entwicklung, neue Marktinitiativen, Produktionsstandorte und -anlagen, Stärken und Schwächen des Unternehmens, Produkteinführung, Produkttestpipelines, Produktzulassungen, Patente, Produktbreite und -breite, Anwendungsdominanz, Technologie-Lebenslinienkurve. Die oben angegebenen Datenpunkte beziehen sich nur auf den Fokus des Unternehmens auf den Markt für Herzklappengeräte.

Zu den Hauptakteuren auf dem Markt für Herzklappengeräte zählen unter anderem Abbott, Boston Scientific Corporation oder deren Tochtergesellschaften, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc. und Colibri Heart Valve.

Forschungsmethodik: Globaler Markt für Herzklappengeräte

Die Datenerfassung und die Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Die wichtigste Forschungsmethode, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, Analyse der Auswirkungen von Datenvariablen auf den Markt und primäre (Branchenexperten-)Validierung umfasst. Abgesehen davon umfassen die Datenmodelle ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, einen Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Firmenmarktanteilsanalyse, Messstandards, global vs. regional und eine Lieferantenanteilsanalyse. Bitte fordern Sie bei weiteren Fragen einen Analystenanruf an.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen im Bereich der modernen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersichten, Analysen des Marktes für aufgearbeitete Produkte und der Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien durchgeführt werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten benötigen, und zwar in dem von Ihnen gewünschten Format und Datenstil. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien, Pivot-Tabellen (Factbook) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

SKU-32918

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Klicken Sie auf das Bild, um es zu vergrößern

Interaktives Datenanalyse-Dashboard
Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
Zugriff für Research-Analysten für Anpassungen und Abfragen
Konkurrenzanalyse mit interaktivem Dashboard
Aktuelle Nachrichten, Updates und Trendanalyse
Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung

Demo anfordern

Inhaltsverzeichnis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE GLOBAL HEART VALVE DEVICES MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 SOURCE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

3.1 EPIDEMIOLOGY

3.2 PESTEL ANALYSIS

3.3 PORTER'S FIVE FORCE

4 MARKET OVERVIEW

4.1 DRIVERS

4.1.1 INNOVATIONS IN HEART VALVE DEVICES OFFER IMPROVED CLINICAL OUTCOME

4.1.2 RISING NUMBER OF VARIOUS HEART DISEASES

4.1.3 ADVANCEMENTS IN TRANSCATHETER VALVE TECHNOLOGY

4.1.4 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES

4.2 RESTRAINTS

4.2.1 HIGH COST ASSOCIATED WITH THE SURGERIES

4.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT

4.3 OPPORTUNITIES

4.3.1 INCREASING AWARENESS OF PROSTHETIC DEVICES

4.3.2 RISING PREVALENCE OF STROKE & CARDIAC ARREST TO REINFORCE DEMAND FOR HEART VALVE DEVICES

4.3.3 INCREASING FDA APPROVALS OF TRANSCATHETER AORTIC VALVES

4.4 CHALLENGES

4.4.1 STRICT GOVERNMENT REGULATIONS

4.4.2 EXPENSIVE PRODUCTION COST OF EQUIPMENT

5 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE

5.1 OVERVIEW

5.2 MECHANICAL HEART VALVES

5.2.1 AORTIC VALVE

5.2.2 MITRAL VALVE

5.3 BIOLOGICAL HEART VALVES

5.3.1 AORTIC VALVE

5.3.2 MITRAL VALVE

5.3.3 PULMONARY VALVE

5.3.4 TRICUSPID VALVE

5.4 TRANSCATHETER VALVE

5.4.1 AORTIC VALVE

5.4.2 MITRAL VALVE

5.4.3 PULMONARY VALVE

6 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT

6.1 OVERVIEW

6.2 MINIMALLY INVASIVE SURGERY (MIS)

6.2.1 CARDIAC VALVE REPLACEMENT

6.2.2 CARDIAC VALVE REPAIR

6.3 OPEN SURGERY

6.3.1 CARDIAC VALVE REPLACEMENT

6.3.2 CARDIAC VALVE REPAIR

7 GLOBAL HEART VALVE DEVICES MARKET, BY END USER

7.1 OVERVIEW

7.2 HOSPITAL & CLINICS

7.3 AMBULATORY SURGICAL CENTERS

7.4 CARDIAC CENTERS

7.5 RESEARCH CENTERS

7.6 OTHERS

8 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW

8.2 DIRECT TENDER

8.3 THIRD PARTY DISTRIBUTORS

9 GLOBAL HEART VALVE DEVICES MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 U.S.

9.2.2 CANADA

9.2.3 MEXICO

9.3 SOUTH AMERICA

9.3.1 BRAZIL

9.3.2 ARGENTINA

9.3.3 REST OF SOUTH AMERICA

9.4 EUROPE

9.4.1 GERMANY

9.4.2 FRANCE

9.4.3 U.K.

9.4.4 ITALY

9.4.5 RUSSIA

9.4.6 SPAIN

9.4.7 TURKEY

9.4.8 NETHERLANDS

9.4.9 SWITZERLAND

9.4.10 BELGIUM

9.4.11 DENMARK

9.4.12 SWEDEN

9.4.13 POLAND

9.4.14 NORWAY

9.4.15 FINLAND

9.4.16 REST OF EUROPE

9.5 ASIA-PACIFIC

9.5.1 CHINA

9.5.2 JAPAN

9.5.3 SOUTH KOREA

9.5.4 INDIA

9.5.5 AUSTRALIA

9.5.6 SINGAPORE

9.5.7 TAIWAN

9.5.8 THAILAND

9.5.9 MALAYSIA

9.5.10 INDONESIA

9.5.11 PHILIPPINES

9.5.12 NEW ZEALAND

9.5.13 VIETNAM

9.5.14 REST OF ASIA-PACIFIC

9.6 MIDDLE EAST AND AFRICA

9.6.1 SOUTH AFRICA

9.6.2 SAUDI ARABIA

9.6.3 U.A.E.

9.6.4 EGYPT

9.6.5 ISRAEL

9.6.6 KUWAIT

9.6.7 QATAR

9.6.8 OMAN

9.6.9 BAHRAIN

9.6.10 REST OF MIDDLE EAST AND AFRICA

10 GLOBAL HEART VALVE DEVICES MARKET: COMPANY LANDSCAPE

10.1 COMPANY SHARE ANALYSIS: GLOBAL

10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA

10.3 COMPANY SHARE ANALYSIS: EUROPE

10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

11 SWOT ANALYSIS

12 COMPANY PROFILE

12.1 MEDTRONIC

12.1.1 COMPANY SNAPSHOT

12.1.2 REVENUE ANALYSIS

12.1.3 COMPANY SHARE ANALYSIS

12.1.4 PRODUCT PORTFOLIO

12.1.5 RECENT DEVELOPMENTS

12.2 EDWARDS LIFESCIENCES CORPORATION

12.2.1 COMPANY SNAPSHOT

12.2.2 REVENUE ANALYSIS

12.2.3 COMPANY SHARE ANALYSIS

12.2.4 PRODUCT PORTFOLIO

12.2.5 RECENT DEVELOPMENTS

12.3 ABBOTT

12.3.1 COMPANY SNAPSHOT

12.3.2 REVENUE ANALYSIS

12.3.3 COMPANY SHARE ANALYSIS

12.3.4 PRODUCT PORTFOLIO

12.3.5 RECENT DEVELOPMENTS

12.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.

12.4.1 COMPANY SNAPSHOT

12.4.2 REVENUE ANALYSIS

12.4.3 COMPANY SHARE ANALYSIS

12.4.4 PRODUCT PORTFOLIO

12.4.5 RECENT DEVELOPMENT

12.5 ARTIVION, INC.

12.5.1 COMPANY SNAPSHOT

12.5.2 REVENUE ANALYSIS

12.5.3 COMPANY SHARE ANALYSIS

12.5.4 PRODUCT PORTFOLIO

12.5.5 RECENT DEVELOPMENTS

12.6 COLIBRI HEART VALVE

12.6.1 COMPANY SNAPSHOT

12.6.2 PRODUCT PORTFOLIO

12.6.3 RECENT DEVELOPMENTS

12.7 FOLDAX, INC.

12.7.1 COMPANY SNAPSHOT

12.7.2 PRODUCT PORTFOLIO

12.7.3 RECENT DEVELOPMENTS

12.8 MERIL LIFE SCIENCES PVT. LTD.

12.8.1 COMPANY SNAPSHOT

12.8.2 PRODUCT PORTFOLIO

12.8.3 RECENT DEVELOPMENTS

12.9 MICRO INTERVENTIONAL DEVICES, INCORPORATED.

12.9.1 COMPANY SNAPSHOT

12.9.2 PRODUCT PORTFOLIO

12.9.3 RECENT DEVELOPMENTS

12.1 NEOVASC

12.10.1 COMPANY SNAPSHOT

12.10.2 REVENUE ANALYSIS

12.10.3 PRODUCT PORTFOLIO

12.10.4 RECENT DEVELOPMENTS

12.11 TTK

12.11.1 COMPANY SNAPSHOT

12.11.2 REVENUE ANALYSIS

12.11.3 PRODUCT PORTFOLIO

12.11.4 RECENT DEVELOPMENTS

12.12 VENUS MEDTECH (HANGZHOU) INC.

12.12.1 COMPANY SNAPSHOT

12.12.2 REVENUE ANALYSIS

12.12.3 PRODUCT PORTFOLIO

12.12.4 RECENT DEVELOPMENTS

12.13 XELTIS

12.13.1 COMPANY SNAPSHOT

12.13.2 PRODUCT PORTFOLIO

12.13.3 RECENT DEVELOPMENTS

13 QUESTIONNAIRE

14 RELATED REPORTS

Tabellenverzeichnis

TABLE 1 GLOBAL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 2 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 GLOBAL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 4 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 5 GLOBAL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 6 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 7 GLOBAL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 GLOBAL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 9 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 10 GLOBAL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 11 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 12 GLOBAL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 13 GLOBAL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 14 GLOBAL HOSPITALS & CLINICS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 GLOBAL AMBULATORY SURGICAL CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 16 GLOBAL CARDIAC CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 GLOBAL RESEARCH CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 18 GLOBAL OTHERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 19 GLOBAL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 20 GLOBAL DIRECT TENDER IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 GLOBAL THIRD PARTY DISTRIBUTORS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 22 GLOBAL HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 33 U.S. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 34 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 35 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 36 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 37 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 38 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 39 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 40 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 41 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 42 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 43 U.S. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 44 U.S. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 45 U.S. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 46 U.S. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 47 U.S. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 48 CANADA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 49 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 50 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 51 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 52 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 53 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 54 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 55 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 56 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 57 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 58 CANADA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 59 CANADA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 60 CANADA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 61 CANADA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 62 CANADA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 63 MEXICO HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 64 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 65 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 66 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 67 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 68 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 69 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 70 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 71 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 72 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 73 MEXICO HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 74 MEXICO MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 75 MEXICO OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 76 MEXICO HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 77 MEXICO HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 78 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 79 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 80 SOUTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 81 SOUTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 82 SOUTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 83 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 84 SOUTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 85 SOUTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 86 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 87 SOUTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 88 BRAZIL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 89 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 90 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 91 BRAZIL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 92 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 93 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 94 BRAZIL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 95 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 96 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 97 BRAZIL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 98 BRAZIL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 99 BRAZIL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 100 BRAZIL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 101 BRAZIL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 102 BRAZIL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 103 ARGENTINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 104 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 105 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 106 ARGENTINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 107 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 108 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 109 ARGENTINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 110 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 111 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 112 ARGENTINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 113 ARGENTINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 114 ARGENTINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 115 ARGENTINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 116 ARGENTINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 117 ARGENTINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 118 REST OF SOUTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 119 EUROPE HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 120 EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 121 EUROPE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 122 EUROPE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 123 EUROPE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 124 EUROPE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 125 EUROPE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 126 EUROPE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 127 EUROPE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 128 EUROPE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 129 GERMANY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 130 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 131 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 132 GERMANY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 133 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 134 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 135 GERMANY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 136 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 137 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 138 GERMANY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 139 GERMANY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 140 GERMANY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 141 GERMANY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 142 GERMANY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 143 GERMANY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 144 FRANCE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 145 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 146 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 147 FRANCE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 148 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 150 FRANCE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 151 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 153 FRANCE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 154 FRANCE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 155 FRANCE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 156 FRANCE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 157 FRANCE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 158 FRANCE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 159 U.K. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 160 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 161 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 162 U.K. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 163 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 164 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 165 U.K. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 166 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 167 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 168 U.K. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 169 U.K. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 170 U.K. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 171 U.K. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 172 U.K. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 173 U.K. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 174 ITALY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 175 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 176 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 177 ITALY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 178 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 179 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 180 ITALY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 181 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 182 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 183 ITALY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 184 ITALY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 185 ITALY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 186 ITALY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 187 ITALY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 188 ITALY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 189 RUSSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 191 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 192 RUSSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 193 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 194 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 195 RUSSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 196 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 197 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 198 RUSSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 199 RUSSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 200 RUSSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 201 RUSSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 202 RUSSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 203 RUSSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 204 SPAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 205 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 206 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 207 SPAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 208 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 209 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 210 SPAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 211 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 213 SPAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 214 SPAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 215 SPAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 216 SPAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 217 SPAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 218 SPAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 219 TURKEY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 220 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 221 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 222 TURKEY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 223 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 224 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 225 TURKEY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 226 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 227 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 228 TURKEY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 229 TURKEY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 230 TURKEY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 231 TURKEY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 232 TURKEY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 233 TURKEY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 234 NETHERLANDS HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 235 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 236 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 237 NETHERLANDS MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 238 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 239 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 240 NETHERLANDS BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 241 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 242 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 243 NETHERLANDS TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 244 NETHERLANDS HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 245 NETHERLANDS MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 246 NETHERLANDS OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 247 NETHERLANDS HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 248 NETHERLANDS HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 249 SWITZERLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 250 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 251 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 252 SWITZERLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 253 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 254 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 255 SWITZERLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 256 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 257 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 258 SWITZERLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 259 SWITZERLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 260 SWITZERLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 261 SWITZERLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 262 SWITZERLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 263 SWITZERLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 264 BELGIUM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 265 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 266 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 267 BELGIUM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 268 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 269 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 270 BELGIUM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 271 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 272 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 273 BELGIUM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 274 BELGIUM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 275 BELGIUM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 276 BELGIUM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 277 BELGIUM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 278 BELGIUM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 279 DENMARK HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 280 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 282 DENMARK MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 283 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 284 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 285 DENMARK BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 286 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 287 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 288 DENMARK TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 289 DENMARK HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 290 DENMARK MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 291 DENMARK OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 292 DENMARK HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 293 DENMARK HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 294 SWEDEN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 295 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 296 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 297 SWEDEN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 298 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 299 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 300 SWEDEN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 301 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 302 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 303 SWEDEN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 304 SWEDEN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 305 SWEDEN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 306 SWEDEN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 307 SWEDEN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 308 SWEDEN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 309 POLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 310 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 311 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 312 POLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 313 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 314 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 315 POLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 316 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 317 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 318 POLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 319 POLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 320 POLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 321 POLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 322 POLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 323 POLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 324 NORWAY HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 325 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 326 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 327 NORWAY MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 328 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 329 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 330 NORWAY BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 331 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 332 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 333 NORWAY TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 334 NORWAY HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 335 NORWAY MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 336 NORWAY OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 337 NORWAY HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 338 NORWAY HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 339 FINLAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 340 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 341 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 342 FINLAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 343 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 345 FINLAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 346 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 347 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 348 FINLAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 349 FINLAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 350 FINLAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 351 FINLAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 352 FINLAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 353 FINLAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 354 REST OF EUROPE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 355 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 356 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 357 ASIA-PACIFIC MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 358 ASIA-PACIFIC BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 359 ASIA-PACIFIC TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 360 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 361 ASIA-PACIFIC MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 362 ASIA-PACIFIC OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 363 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 364 ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 365 CHINA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 366 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 367 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 368 CHINA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 369 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 370 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 371 CHINA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 372 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 373 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 374 CHINA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 375 CHINA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 376 CHINA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 377 CHINA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 378 CHINA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 379 CHINA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 380 JAPAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 381 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 382 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 383 JAPAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 384 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 385 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 386 JAPAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 387 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 388 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 389 JAPAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 390 JAPAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 391 JAPAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 392 JAPAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 393 JAPAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 394 JAPAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 395 SOUTH KOREA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 396 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 397 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 398 SOUTH KOREA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 399 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 400 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 401 SOUTH KOREA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 402 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 403 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 404 SOUTH KOREA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 405 SOUTH KOREA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 406 SOUTH KOREA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 407 SOUTH KOREA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 408 SOUTH KOREA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 409 SOUTH KOREA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 410 INDIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 411 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 412 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 413 INDIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 414 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 415 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 416 INDIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 417 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 418 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 419 INDIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 420 INDIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 421 INDIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 422 INDIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 423 INDIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 424 INDIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 425 AUSTRALIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 426 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 427 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 428 AUSTRALIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 429 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 430 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 431 AUSTRALIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 432 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 433 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 434 AUSTRALIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 435 AUSTRALIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 436 AUSTRALIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 437 AUSTRALIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 438 AUSTRALIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 439 AUSTRALIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 440 SINGAPORE HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 441 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 442 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 443 SINGAPORE MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 444 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 445 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 446 SINGAPORE BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 447 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 448 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 449 SINGAPORE TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 450 SINGAPORE HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 451 SINGAPORE MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 452 SINGAPORE OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 453 SINGAPORE HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 454 SINGAPORE HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 455 TAIWAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 456 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 457 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 458 TAIWAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 459 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 460 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 461 TAIWAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 462 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 463 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 464 TAIWAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 465 TAIWAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 466 TAIWAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 467 TAIWAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 468 TAIWAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 469 TAIWAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 470 THAILAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 471 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 472 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 473 THAILAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 474 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 475 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 476 THAILAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 477 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 478 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 479 THAILAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 480 THAILAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 481 THAILAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 482 THAILAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 483 THAILAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 484 THAILAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 485 MALAYSIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 486 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 487 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 488 MALAYSIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 489 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 490 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 491 MALAYSIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 492 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 493 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 494 MALAYSIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 495 MALAYSIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 496 MALAYSIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 497 MALAYSIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 498 MALAYSIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 499 MALAYSIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 500 INDONESIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 501 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 502 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 503 INDONESIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 504 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 505 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 506 INDONESIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 507 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 508 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 509 INDONESIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 510 INDONESIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 511 INDONESIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 512 INDONESIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 513 INDONESIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 514 INDONESIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 515 PHILIPPINES HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 516 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 517 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 518 PHILIPPINES MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 519 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 520 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 521 PHILIPPINES BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 522 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 523 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 524 PHILIPPINES TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 525 PHILIPPINES HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 526 PHILIPPINES MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 527 PHILIPPINES OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 528 PHILIPPINES HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 529 PHILIPPINES HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 530 NEW ZEALAND HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 531 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 532 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 533 NEW ZEALAND MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 534 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 535 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 536 NEW ZEALAND BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 537 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 538 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 539 NEW ZEALAND TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 540 NEW ZEALAND HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 541 NEW ZEALAND MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 542 NEW ZEALAND OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 543 NEW ZEALAND HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 544 NEW ZEALAND HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 545 VIETNAM HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 546 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 547 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 548 VIETNAM MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 549 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 550 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 551 VIETNAM BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 552 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 553 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 554 VIETNAM TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 555 VIETNAM HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 556 VIETNAM MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 557 VIETNAM OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 558 VIETNAM HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 559 VIETNAM HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 560 REST OF ASIA-PACIFIC HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 561 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 562 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 563 MIDDLE EAST AND AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 564 MIDDLE EAST AND AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 565 MIDDLE EAST AND AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 566 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 567 MIDDLE EAST AND AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 568 MIDDLE EAST AND AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 569 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 570 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 571 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 572 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 573 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 574 SOUTH AFRICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 575 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 576 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 577 SOUTH AFRICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 578 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 579 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 580 SOUTH AFRICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 581 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 582 SOUTH AFRICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 583 SOUTH AFRICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 584 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 585 SOUTH AFRICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 586 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 587 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 588 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 589 SAUDI ARABIA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 590 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 591 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 592 SAUDI ARABIA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 593 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 594 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 595 SAUDI ARABIA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 596 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 597 SAUDI ARABIA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 598 SAUDI ARABIA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 599 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 600 SAUDI ARABIA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 601 U.A.E. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 602 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 603 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 604 U.A.E. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 605 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 606 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 607 U.A.E. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 608 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 609 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)

TABLE 610 U.A.E. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)

TABLE 611 U.A.E. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 612 U.A.E. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 613 U.A.E. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 614 U.A.E. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 615 U.A.E. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 616 EGYPT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 617 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 618 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 619 EGYPT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 620 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 621 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 622 EGYPT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 623 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 624 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 625 EGYPT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 626 EGYPT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 627 EGYPT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 628 EGYPT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 629 EGYPT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 630 EGYPT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 631 ISRAEL HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 632 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 633 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 634 ISRAEL MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 635 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 636 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 637 ISRAEL BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 638 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 639 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 640 ISRAEL TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 641 ISRAEL HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 642 ISRAEL MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 643 ISRAEL OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 644 ISRAEL HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 645 ISRAEL HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 646 KUWAIT HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 647 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 648 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 649 KUWAIT MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 650 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 651 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 652 KUWAIT BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 653 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 654 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 655 KUWAIT TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 656 KUWAIT HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 657 KUWAIT MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 658 KUWAIT OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 659 KUWAIT HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 660 KUWAIT HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 661 QATAR HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 662 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 663 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 664 QATAR MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 665 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 666 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 667 QATAR BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 668 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 669 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 670 QATAR TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 671 QATAR HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 672 QATAR MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 673 QATAR OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 674 QATAR HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 675 QATAR HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 676 OMAN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 677 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 678 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 679 OMAN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 680 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 681 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 682 OMAN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 683 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 684 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 685 OMAN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 686 OMAN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 687 OMAN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 688 OMAN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 689 OMAN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 690 OMAN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 691 BAHRAIN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 692 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 693 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 694 BAHRAIN MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 695 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 696 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 697 BAHRAIN BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 698 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 699 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (USD)

TABLE 700 BAHRAIN TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (UNITS)

TABLE 701 BAHRAIN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 702 BAHRAIN MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 703 BAHRAIN OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)

TABLE 704 BAHRAIN HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 705 BAHRAIN HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 706 REST OF MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

Abbildungsverzeichnis

FIGURE 1 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION

FIGURE 2 GLOBAL HEART VALVE DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL HEART VALVE DEVICES MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL HEART VALVE DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL HEART VALVE DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL HEART VALVE DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL HEART VALVE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 GLOBAL HEART VALVE DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL HEART VALVE DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL HEART VALVE DEVICES MARKET: SEGMENTATION

FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL HEART VALVE DEVICES MARKET, AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD

FIGURE 12 GROWING PREVALENCE OF VALVULAR DISEASES, SUCH AS AORTIC STENOSIS & AORTIC REGURGITATION, AND INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES ARE EXPECTED TO DRIVE THE GLOBAL HEART VALVE DEVICES MARKET IN THE FORECAST PERIOD

FIGURE 13 MECHANICAL HEART VALVE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL HEART VALVE DEVICES MARKET IN 2023 & 2030

FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR HEART VALVE DEVICES MANUFACTURERS IN THE FORECAST PERIOD

FIGURE 15 INCIDENDE AND PREVALENCE OF HEART VALVE OF NORTH AMERICA

FIGURE 16 INCIDENDE AND PREVALENCE OF HEART VALVE OF EUROPE

FIGURE 17 INCIDENDE AND PREVALENCE OF HEART VALVE OF ASIA-PACIFIC

FIGURE 18 INCIDENDE AND PREVALENCE OF HEART VALVE OF SOUTH AMERICA & MIDDLE EAST AND AFRICA

FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL HEART VALVE DEVICES MARKET

FIGURE 20 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2022

FIGURE 21 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)

FIGURE 22 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, CAGR (2023-2030)

FIGURE 23 GLOBAL HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 24 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2022

FIGURE 25 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, 2023-2030 (USD MILLION)

FIGURE 26 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, CAGR (2023-2030)

FIGURE 27 GLOBAL HEART VALVE DEVICES MARKET : BY TREATMENT, LIFELINE CURVE

FIGURE 28 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2022

FIGURE 29 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, 2023-2030 (USD MILLION)

FIGURE 30 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, CAGR (2023-2030)

FIGURE 31 GLOBAL HEART VALVE DEVICES MARKET : BY END USER, LIFELINE CURVE

FIGURE 32 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2022

FIGURE 33 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 34 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 35 GLOBAL HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 36 GLOBAL HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 37 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022)

FIGURE 38 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2023 & 2030)

FIGURE 39 GLOBAL HEART VALVE DEVICES MARKET: BY REGION (2022 & 2030)

FIGURE 40 GLOBAL HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 41 NORTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 42 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 43 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 44 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 45 NORTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 46 SOUTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 47 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 48 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 49 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 50 SOUTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 51 EUROPE HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 52 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 53 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 54 EUROPE HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 55 EUROPE HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 56 ASIA-PACIFIC HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 57 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 58 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 59 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 60 ASIA-PACIFIC HEART VALVE DEVICES MARKET: BY FUNCTIONALITY (2023-2030)

FIGURE 61 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)

FIGURE 62 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)

FIGURE 63 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)

FIGURE 64 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)

FIGURE 65 MIDDLE EAST AND AFRICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)

FIGURE 66 GLOBAL HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 67 NORTH AMERICA HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 68 EUROPE HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

FIGURE 69 ASIA-PACIFIC HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)

Detaillierte Informationen anzeigen

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

How big is the Heart Valve Devices Market?

The Heart Valve Devices Market size will be worth USD 23,665.51 million by 2030 during the forecast period.

What is the growth rate of the Heart Valve Devices Market?

The Heart Valve Devices Market growth rate is 13.4% during the forecast period.

What are the growth drivers of the Heart Valve Devices Market?

The Innovations in Heart Valve Devices Offer Improved Clinical Outcome and Rising number of various heart diseases are the growth drivers of the Heart Valve Devices Market.

What are the factors on which the Heart Valve Devices Market research is based on?

The product type, treatment, end user, and distribution channel are the factors on which the Heart Valve Devices Market research is based.

Which are the major companies in the Heart Valve Devices Market?

The major companies in the Heart Valve Devices Market are Abbott, Boston Scientific Corporation or its affiliates, Artivion, Inc., Edwards Lifesciences Corporation, Medtronic, NeoVasc, Micro Interventional Devices Incorporated, XELTIS, TTK, Meril Life Sciences Pvt. Ltd, Foldax, Inc., Venus Medtech (Hangzhou) Inc., Colibri Heart Valve.

Weltweiter Markt für Herzklappengeräte – Branchentrends und Prognose bis 2030

Weltweiter Markt für Herzklappengeräte – Branchentrends und Prognose bis 2030

Global Heart Valve Devices Market

CAGR : 13.40 %

Marktanalyse und Einblicke zu Herzklappengeräten

Globale Marktdefinition für Herzklappengeräte

Globale Marktdynamik für Herzklappengeräte

Globaler Markt für Herzklappengeräte

Globaler Markt für Herzklappengeräte – Regionale Analyse/Einblicke

Wettbewerbsumfeld und globale Marktanteilsanalyse für Herzklappengeräte

Forschungsmethodik: Globaler Markt für Herzklappengeräte

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Inhaltsverzeichnis

Tabellenverzeichnis

Abbildungsverzeichnis

Forschungsmethodik

Anpassung möglich

Häufig gestellte Fragen

Berichte

Markteinblicke

Unterstützung

Lösungen

Weltweiter Markt für Herzklappengeräte – Branchentrends und Prognose bis 2030

Weltweiter Markt für Herzklappengeräte – Branchentrends und Prognose bis 2030

Global Heart Valve Devices Market

CAGR : 13.40 %

Marktanalyse und Einblicke zu Herzklappengeräten

Globale Marktdefinition für Herzklappengeräte

Globale Marktdynamik für Herzklappengeräte

Globaler Markt für Herzklappengeräte

Globaler Markt für Herzklappengeräte – Regionale Analyse/Einblicke

Wettbewerbsumfeld und globale Marktanteilsanalyse für Herzklappengeräte

Forschungsmethodik: Globaler Markt für Herzklappengeräte

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

Inhaltsverzeichnis

Tabellenverzeichnis

Abbildungsverzeichnis

Forschungsmethodik

Anpassung möglich

Häufig gestellte Fragen

Verwandte Seiten durchsuchen